Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response.

Autor: Ferreira, Amanda Pifano Soares, Seguro, Fernanda Salles, Abdo, Andre Ramires Neder, Santos, Fernanda Maria, Maciel, Felipe Vieira Rodrigues, Nardinelli, Luciana, Giorgi, Ricardo Rodrigues, Ruiz, Antonio Roberto Lancha, Ferreira, Milton Pifano Soares, Rego, Eduardo Magalhaes, Rocha, Vanderson, Bendit, Israel
Předmět:
Zdroj: Annals of Hematology; Jul2023, Vol. 102 Issue 7, p1969-1969, 1p
Abstrakt: B Correction to: Annals of Hematology b https://doi.org/10.1007/s00277-023-05189-3 In the published paper, almost all the figures and tables of the article (Table 1, table 2, figure 3, figure 4, figure 5 and figure 6 are incompatible with its current captions. Correction to: Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response The original article can be found online at https://doi.org/10.1007/s00277-023-05189-3. [Extracted from the article]
Databáze: Complementary Index
Externí odkaz: